Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2023 - 01 - 25 save search
Sonoma Pharmaceuticals and EMC Pharma Announce Department of Defense DAPA Registration for Microcyn(R) Rx Products
Published: 2023-01-25 (Crawled : 14:20) - biospace.com/
SNOA | $0.16 0.63% -2.58% 120K
|
Health Technology
|
| O: 65.83%
H: 34.67%
C: -15.08%
pharmaceuticals pharma defense
First Wave BioPharma Announces Expansion of Adrulipase Intellectual Property Portfolio
Published: 2023-01-25 (Crawled : 12:00) - globenewswire.com
FWBI | $3.02 -3.21% -2.63% 36K
|
Manufacturing
|
| O: 58.37%
H: 7.0%
C: -22.86%
biopharma expansion adrulipase
Millicom (Tigo) confirms discussions on a potential transaction
Published: 2023-01-25 (Crawled : 17:00) - globenewswire.com
TIGO | $20.16 -0.89% -0.89% 41K
|
Communications
|
| O: 18.27%
H: 4.39%
C: 4.05%
potential
Vision Energy Engineering Progress Report
Published: 2023-01-25 (Crawled : 13:00) - globenewswire.com
VENG | $0.0014 400.0% 290
|
n/a
|
| O: 17.0%
H: 19.66%
C: 17.95%
energy report
180 Life Sciences Announces Publication of a Review on the Treatments for Early Stage Dupuytren’s Disease
Published: 2023-01-25 (Crawled : 14:00) - globenewswire.com
ATNF | $1.82 -4.21% -4.97% 17K
|
|
| O: 15.77%
H: 45.78%
C: 15.53%
Cidara Therapeutics and Melinta Therapeutics Announce FDA Advisory Committee Recommends Approval of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis
Published: 2023-01-25 (Crawled : 12:00) - globenewswire.com
CDTX | News | $12.29 19.9% 14.15% 57K
|
Health Technology
|
| O: 15.29%
H: 21.5%
C: 19.63%
treatment fda candidiasis approval therapeutics rezafungin candidemia
Inhibikase Therapeutics Announces FDA has Lifted the Full Clinical Hold on IkT-148009 in Parkinson's Disease
Published: 2023-01-25 (Crawled : 13:20) - prnewswire.com
IKT | $1.87 18.35% 3.66% 62K
|
Health Technology
|
| O: 9.85%
H: 15.78%
C: -13.97%
fda disease ikt-148009 lifted parkinson's therapeutics clinical hold
Inhibikase Therapeutics Announces Publication Demonstrating Potential for c-Abl as a Key Therapeutic Target in Parkinson's Disease and Related Disorders
Published: 2023-01-25 (Crawled : 14:00) - prnewswire.com
IKT | $1.87 18.35% 3.66% 62K
|
Health Technology
|
| O: 9.85%
H: 15.78%
C: -13.97%
c-abl disease parkinson's therapeutics potential publication
Inhibikase Therapeutics Announces $10 Million Concurrent Registered Direct Offering and Private Placement Priced at a Premium to Market Under Nasdaq Rules
Published: 2023-01-25 (Crawled : 23:00) - biospace.com/
IKT | $1.87 18.35% 3.66% 62K
|
Health Technology
|
| O: 9.85%
H: 15.78%
C: -13.97%
offering nasdaq therapeutics direct market
Millennium Management Llc Increases Position in Vector Acquisition … – Nasdaq
Published: 2023-01-25 (Crawled : 22:00) - spacfeed.com
LCII 4 | $109.42 -1.49% 0.0% 170K
|
Producer Manufacturing
|
| O: -2.12%
H: 2.65%
C: 2.61%
EXPR | $0.83 18.57% -9.64% 0
|
Retail Trade
|
| O: 9.71%
H: 1.77%
C: -2.65%
acquisition management nasdaq
Express, Inc. Announces Closing of Transaction to Initiate Strategic … – Business Wire
Published: 2023-01-25 (Crawled : 22:00) - spacfeed.com
LCII 4 | $109.42 -1.49% 0.0% 170K
|
Producer Manufacturing
|
| O: -2.12%
H: 2.65%
C: 2.61%
EXPR | $0.83 18.57% -9.64% 0
|
Retail Trade
|
| O: 9.71%
H: 1.77%
C: -2.65%
VIVEON HEALTH ACQUISITION CORP. Announces Adjournment of Special Meeting in Connection with Vote to Consummate its Initial Business Combination with Suneva Medical, Inc. Until February 3, 2023.
Published: 2023-01-25 (Crawled : 18:00) - globenewswire.com
VHAQ | $10.81 0.0% 990
|
|
| O: 9.44%
H: 0.45%
C: -2.25%
acquisition meeting health
Viveon Health Acquisition Pushes Extension Vote Back to Next Week
Published: 2023-01-25 (Crawled : 18:00) - spacfeed.com
VHAQ | $10.81 0.0% 990
|
|
| O: 9.44%
H: 0.45%
C: -2.25%
acquisition extension health back week
VIVEON HEALTH ACQUISITION CORP. Announces Adjournment of … – GlobeNewswire
Published: 2023-01-25 (Crawled : 18:00) - spacfeed.com
VHAQ | $10.81 0.0% 990
|
|
| O: 9.44%
H: 0.45%
C: -2.25%
acquisition health
VIVEON HEALTH ACQUISITION CORP. Announces Adjournment of Special Meeting in Connection with Vote to Consummate its Initial Business Combination with Suneva Medical, Inc. Until February 3, 2023. – Yahoo Finance
Published: 2023-01-25 (Crawled : 18:00) - spacfeed.com
VHAQ | $10.81 0.0% 990
|
|
| O: 9.44%
H: 0.45%
C: -2.25%
acquisition meeting health
Seaport Global II Signs Non-Redemption Agreement for 200K Shares
Published: 2023-01-25 (Crawled : 18:00) - spacfeed.com
VHAQ | $10.81 0.0% 990
|
|
| O: 9.44%
H: 0.45%
C: -2.25%
global agreement
Decarbonization Plus IV Shareholders Approve Hammerhead Deal
Published: 2023-01-25 (Crawled : 18:00) - spacfeed.com
VHAQ | $10.81 0.0% 990
|
|
| O: 9.44%
H: 0.45%
C: -2.25%
deal plus
Noble Rock Acquisition Sells Sponsor Control
Published: 2023-01-25 (Crawled : 18:00) - spacfeed.com
VHAQ | $10.81 0.0% 990
|
|
| O: 9.44%
H: 0.45%
C: -2.25%
acquisition control rock
Decatur School Board discusses ESPLOST funding, projects … – Decaturish.com
Published: 2023-01-25 (Crawled : 18:00) - spacfeed.com
VHAQ | $10.81 0.0% 990
|
|
| O: 9.44%
H: 0.45%
C: -2.25%
Highbridge Capital Management Llc Cuts Stake in 7GC & Co … – Nasdaq
Published: 2023-01-25 (Crawled : 18:00) - spacfeed.com
VHAQ | $10.81 0.0% 990
|
|
| O: 9.44%
H: 0.45%
C: -2.25%
management nasdaq
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.